Clinical significance of α-fetoprotein mRNA during perioperative period in HCC

Hepato-Gastroenterology

Volumn 46, Issue 25, 1999, Pages 381-386

  Okuda, Naoto ^a   Nakao, Akimasa ^b   Takeda, Shin ^b   Oshima, Kenji ^b   Kanazumi, Naohito ^b   Nonami, Toshiaki ^b   Kurokawa, Tsuyoshi ^b   Takagi, Hiroshi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Alternation of perioperative period; Hepatocellular carcinoma; Human AFPmRNA; Reverse transcriptase polymerase chain reaction

Indexed keywords

ALPHA FETOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CARCINOMA CELL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; MALE; METASTASIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; POSTOPERATIVE PERIOD; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0033059483     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. 1 Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, Tanioka H, Yano M, Nagataki S: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 1994; 74:2234-2238.
2. 2 Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H: Hepatic resection for hepatocellular carcinoma. Am J Surg 1997; 173:288-291.
3. 3 Inoue S, Nakao A, Harada A, Nonami T, Takagi H: Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma. Am J Gastroenterol 1994; 89:2222-2226.
4. 4 Nakao A, Taniguchi K, Inoue S, Harada A, Nonami T, Watanabe K, Takagi H: Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma. Semin Surg Oncol 1996; 12:160-163.
5. 5 Soeth E, Roder C, Juhl H, Kruger U, Kremer B, Kalthoff H: The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996; 69:278-282.
6. 6 Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340:685-689.
7. 7 Kruger WH, Stockschlader M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Loliger C, Gieseking F, Jonat W, Zander AR: Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transpl 1996; 18:S18-20.
8. 8 Kruger W, Krzizanowski C, Holweg M, Stockschlader M, Kroger N, Jung R, Mross K, Jonat W, Zander AR: Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncology 1996; 122:679-686.
9. 9 Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-1229.
10. 10 Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zanker KS: Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 1996; 56:4556-4561.
11. 11 Nomoto S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H: Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res 1996; 87:793-797.
12. 12 Kar S, Carr B: Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma. Hepatol 1995; 21:403-407.
13. 13 Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R: Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterol 1994; 106:239-242.
14. 14 Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y, et al: Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatol 1994; 20:1418-1425.
15. 15 Funaki N, Tanaka J, Seto S, Kasamatsu T, Kaido T, Imamura M: Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients. Life Sci 1995; 57:1621-1631.
16. 16 Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Imamura M: Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatol 1997; 25:564-568.
17. 17 Taketa K: Alpha-fetoprotein: revaluation in hepatology. Hepatol 1990; 12:1420-1432.
18. 18 Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K: Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75:2214-2219.
19. 19 Nambu S, Nishimori H, Saeki M, Higuchi K, Watanabe A: α-Fetoprotein messenger RNA in peripheral blood as a marker of circulating hepatocellular carcinoma cells. Int Hepatol Commun 1995; 5:217-221.
20. 20 Morinaga T, Sakai M, Wegmann TG, Tamaoki T: Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci USA 1983; 80:4604-4608.
21. 21 Chelly J, Concordet JP, Kaplan JC, Kahn A: Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989; 86:2617-2621.